Objective: The aim of this study was to highlight the importance of screening for cognitive impairment and depression in End-stage renal disease because cognitive impairment can impair the activities of daily living and overall quality of life Methods: This is a hospital-based cross-sectional study carried out at a nephrology ward. The study was conducted from October 2021 to March 2022. Online WHO sample size calculator was used to find sample size of subject study. One hundred and fifty patients on hemodialysis for more than 1 year were included in the study after taking informed consent. However, those patients who were non-consenting, on drugs that cause cognitive impairment, had pre-existing psychiatric illness, and those who had neurological problems causing cognitive impairment were excluded. Information of the patients regarding age, BMI, gender, education, marital status, cause of renal failure, shift of dialysis, blood pressure, hemoglobin, urea, and creatinine were noted. They were screened for cognitive impairment by using the Montreal cognitive assessment scale, Barthel's index for assessment of activities of daily living, and for depression by using the Hospital Anxiety and Depression Scale. P-value was calculated to see the association between socio-demographic factors and cognitive impairment. Results: Of 150 patients, most were males (56%). Out of these, 36.67% males and 32.67% females were cognitively impaired. Most patients were hypertensive and unemployed. No significant social demographic association was observed for cognitive impairment. The patients with cognitive impairment need assistance in feeding, bathing, and mobility as compared to patients with no cognitive impairment. Conclusion: Our study revealed that cognitive impairment is present in patients, and it is related to activities of daily living. Patients especially need help in climbing stairs, minor help in transferring, occasional bladder help, minor help in feeding, and minor help during walks.